The hospice mergers and acquisitions market has been exploding in recent years, continuing to gain momentum despite pandemic-related pitfalls, Hospice News reports. Still, hospices need to tread lightly and keep a close watch on where they measure up in the highly competitive market, with quality and compliance posing the greatest risks to their value propositions, according to M&A experts.
The three biggest risks for hospice providers during transactions lie in the details of their clinical compliance, quality of earnings and business model, according to David Berman, managing principal of health care mergers and acquisitions for SimiTree Healthcare Consulting. Read more.
